homovanillic acid has been researched along with Substance Withdrawal Syndrome in 65 studies
Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We measured severity of depression with Beck's Depression Inventory (BDI) and Hamilton's Depression Rating Scale (HDRS), plasma concentrations of cortisol, DHEA and DHEA-S, and CSF concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and the dopamine metabolite homovanillic acid (HVA) in 21 abstinent alcoholics after 4 weeks of abstinence and in 11 age-matched healthy control subjects." | 7.70 | Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. ( George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM, 1999) |
| "Increased noradrenergic activity during chronic dopamine blockade may be an episode marker and may predict relapse within 6 weeks following haloperidol withdrawal in schizophrenia." | 7.69 | Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. ( Agren, H; Gurklis, J; O'Connor, DT; Peters, JL; van Kammen, DP; Yao, JK, 1994) |
| "In the week prior to discontinuation of haloperidol treatment, global behavioral ratings and a lumbar puncture for cerebrospinal fluid monoamine metabolities were obtained in 88 patients with chronic schizophrenia." | 7.69 | Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia. ( Gilbertson, MW; Gurklis, JA; Kelley, ME; Peters, JL; van Kammen, DP; Yao, JK, 1995) |
| " We measured severity of depression with Beck's Depression Inventory (BDI) and Hamilton's Depression Rating Scale (HDRS), plasma concentrations of cortisol, DHEA and DHEA-S, and CSF concentrations of the serotonin metabolite 5-hydroxyindoleacetic acid (5-HIAA), the norepinephrine metabolite 3-methoxy-4-hydroxyphenylglycol (MHPG) and the dopamine metabolite homovanillic acid (HVA) in 21 abstinent alcoholics after 4 weeks of abstinence and in 11 age-matched healthy control subjects." | 3.70 | Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. ( George, D; Heinz, A; Hommer, D; Linnoila, M; Weingartner, H; Wolkowitz, OM, 1999) |
| "Increased noradrenergic activity during chronic dopamine blockade may be an episode marker and may predict relapse within 6 weeks following haloperidol withdrawal in schizophrenia." | 3.69 | Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia. ( Agren, H; Gurklis, J; O'Connor, DT; Peters, JL; van Kammen, DP; Yao, JK, 1994) |
| "In the week prior to discontinuation of haloperidol treatment, global behavioral ratings and a lumbar puncture for cerebrospinal fluid monoamine metabolities were obtained in 88 patients with chronic schizophrenia." | 3.69 | Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia. ( Gilbertson, MW; Gurklis, JA; Kelley, ME; Peters, JL; van Kammen, DP; Yao, JK, 1995) |
| " This study evaluated the safety of and pharmacologic interactions between 7 days of transdermal selegiline dosed with patches (Selegiline Transdermal System, STS) that deliver 6 mg/24 hours and 2." | 2.74 | A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion. ( Everhart, T; Harris, DS; Jacob, P; Jones, RT; Lin, E; Mendelson, JE, 2009) |
| "Rats treated with haloperidol also showed an increase in 5-HIAA levels, possibly due to enhanced serotonin turnover." | 1.27 | Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment. ( Barkai, AI; Kowalik, S; Reches, A, 1984) |
| "Clonidine's effectiveness in Tourette's syndrome may be dependent on changes in dopaminergic as well as adrenergic mechanisms." | 1.27 | Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects. ( Anderson, GM; Caruso, KA; Cohen, DJ; Leckman, JF; Ort, S; Riddle, MA, 1986) |
| "Severity of withdrawal symptoms assessed on a rating scale in 14 patients with 4 days or less of abstinence correlated marginally with HVA but not with 5-HIAA." | 1.26 | Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. ( Banki, CM, 1981) |
| "Fluphenazine decanoate was administered chronically to rats on a schedule for which marked tolerance developed to acute fluphenazine effects on several parameters of dopaminergic neuronal function." | 1.26 | Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment. ( Roth, RH; Wheeler, SC, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (50.77) | 18.7374 |
| 1990's | 21 (32.31) | 18.2507 |
| 2000's | 9 (13.85) | 29.6817 |
| 2010's | 2 (3.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirth, N | 1 |
| Meinhardt, MW | 1 |
| Noori, HR | 1 |
| Salgado, H | 1 |
| Torres-Ramirez, O | 1 |
| Uhrig, S | 1 |
| Broccoli, L | 1 |
| Vengeliene, V | 1 |
| Roßmanith, M | 1 |
| Perreau-Lenz, S | 1 |
| Köhr, G | 1 |
| Sommer, WH | 1 |
| Spanagel, R | 1 |
| Hansson, AC | 1 |
| Harris, DS | 1 |
| Everhart, T | 1 |
| Jacob, P | 1 |
| Lin, E | 1 |
| Mendelson, JE | 1 |
| Jones, RT | 1 |
| Okamoto, R | 1 |
| Itoh, Y | 1 |
| Murata, Y | 1 |
| Kobayashi, D | 1 |
| Hosoi, M | 1 |
| Mine, K | 1 |
| Heinz, A | 2 |
| Jones, DW | 1 |
| Bissette, G | 1 |
| Hommer, D | 2 |
| Ragan, P | 1 |
| Knable, M | 1 |
| Wellek, S | 1 |
| Linnoila, M | 5 |
| Weinberger, DR | 2 |
| Roy, A | 2 |
| Berman, J | 1 |
| Gonzalez, B | 1 |
| Roy, M | 1 |
| Diaz, SL | 1 |
| Kemmling, AK | 1 |
| Balerio, GN | 1 |
| Taylor, BK | 1 |
| Basbaum, AI | 1 |
| Carlson, JN | 1 |
| Drew Stevens, K | 1 |
| Köhnke, MD | 1 |
| Lutz, U | 1 |
| Kolb, W | 1 |
| Maurer, S | 1 |
| Wiatr, G | 1 |
| Batra, A | 1 |
| Barkai, AI | 1 |
| Kowalik, S | 1 |
| Reches, A | 1 |
| Clow, A | 1 |
| Theodorou, A | 1 |
| Jenner, P | 1 |
| Marsden, CD | 1 |
| Ahluwalia, P | 1 |
| Singhal, RL | 3 |
| Fujimoto, A | 1 |
| Banki, CM | 1 |
| Petursson, H | 1 |
| Bond, PA | 1 |
| Smith, B | 1 |
| Lader, MH | 1 |
| Allikmets, LKh | 1 |
| Nurk, AM | 1 |
| Swann, AC | 1 |
| Elsworth, JD | 1 |
| Charney, DS | 3 |
| Jablons, DM | 1 |
| Roth, RH | 2 |
| Redmond, DE | 1 |
| Maas, JW | 1 |
| Kuruvilla, A | 1 |
| Fung, YK | 1 |
| Uretsky, NJ | 1 |
| Wheeler, SC | 1 |
| van Kammen, DP | 4 |
| Agren, H | 1 |
| Yao, JK | 3 |
| O'Connor, DT | 1 |
| Gurklis, J | 1 |
| Peters, JL | 2 |
| Kelley, ME | 1 |
| Gurklis, JA | 1 |
| Gilbertson, MW | 2 |
| Honkanen, A | 1 |
| Piepponen, TP | 1 |
| Ahtee, L | 4 |
| Javaid, JI | 1 |
| Notorangelo, MP | 1 |
| Pandey, SC | 1 |
| Reddy, PL | 1 |
| Pandey, GN | 1 |
| Davis, JM | 1 |
| Paulson, PE | 1 |
| Robinson, TE | 1 |
| Uchimura, N | 1 |
| Nakamura, J | 1 |
| Hildebrand, BE | 3 |
| Nomikos, GG | 2 |
| Hertel, P | 1 |
| Schilström, B | 1 |
| Svensson, TH | 3 |
| Bowers, MB | 2 |
| Malison, RT | 1 |
| Seibyl, JP | 1 |
| Kosten, TR | 2 |
| Panagis, G | 1 |
| Petrakis, IL | 1 |
| Trevisan, L | 1 |
| D'Souza, C | 1 |
| Gil, R | 1 |
| Krasnicki, S | 1 |
| Webb, E | 1 |
| Heninger, G | 1 |
| Cooney, N | 1 |
| Krystal, JH | 2 |
| Salminen, O | 1 |
| Seppä, T | 1 |
| Gäddnäs, H | 1 |
| Weingartner, H | 1 |
| George, D | 1 |
| Wolkowitz, OM | 2 |
| Ueda, M | 1 |
| Hamamoto, M | 1 |
| Nagayama, H | 1 |
| Okubo, S | 1 |
| Amemiya, S | 1 |
| Katayama, Y | 1 |
| Rastogi, RB | 2 |
| Lapierre, YD | 2 |
| Winsberg, BG | 1 |
| Hurwic, MJ | 1 |
| Perel, J | 1 |
| Kato, N | 2 |
| Takahashi, S | 2 |
| Tani, N | 2 |
| Iwase, N | 1 |
| Odani, K | 1 |
| Gramsch, C | 1 |
| Bläsig, J | 1 |
| Herz, A | 2 |
| Siever, L | 1 |
| Kraemer, H | 1 |
| Sack, R | 1 |
| Angwin, P | 1 |
| Berger, P | 1 |
| Zarcone, V | 2 |
| Barchas, J | 1 |
| Brodie, HK | 1 |
| Sayers, AC | 1 |
| Bürki, HR | 1 |
| Ruch, W | 1 |
| Asper, H | 1 |
| Kuschinsky, K | 1 |
| Svartström-Fraser, M | 1 |
| McDougle, CJ | 2 |
| Price, LH | 2 |
| Palumbo, JM | 2 |
| Heninger, GR | 3 |
| Kleber, HD | 2 |
| Gil, E | 1 |
| Colado, I | 1 |
| Lopez, F | 1 |
| Fernandez-Briera, A | 1 |
| Fernandez-Lopez, A | 1 |
| Calvo, P | 1 |
| Knoblich, G | 1 |
| Curtis, D | 1 |
| Faustman, WO | 1 |
| Stewart, S | 1 |
| Mefford, I | 1 |
| King, R | 1 |
| Davidson, M | 1 |
| Kahn, RS | 1 |
| Powchik, P | 1 |
| Warne, P | 1 |
| Losonczy, MF | 1 |
| Kaminsky, R | 1 |
| Apter, S | 1 |
| Jaff, S | 1 |
| Davis, KL | 1 |
| Carey, RJ | 1 |
| Satel, SL | 1 |
| Gawin, F | 1 |
| Robertson, MW | 1 |
| Leslie, CA | 1 |
| Bennett, JP | 1 |
| Hollander, E | 1 |
| Nunes, E | 1 |
| DeCaria, CM | 1 |
| Quitkin, FM | 1 |
| Cooper, T | 1 |
| Wager, S | 1 |
| Klein, DF | 1 |
| Modai, I | 1 |
| Beigel, Y | 1 |
| Cygielman, G | 1 |
| Attila, P | 1 |
| Lauhakangas, V | 1 |
| Solkinen, A | 1 |
| Sipilä, J | 1 |
| Peters, J | 1 |
| van Kammen, WB | 1 |
| Nugent, A | 1 |
| Goetz, KL | 1 |
| Yao, J | 1 |
| Glazer, WM | 1 |
| Bagdy, G | 2 |
| Perényi, A | 2 |
| Frecska, E | 2 |
| Révai, K | 2 |
| Papp, Z | 1 |
| Fekete, MI | 1 |
| Arató, M | 1 |
| Martin, SD | 1 |
| Yeragani, VK | 1 |
| Lodhi, R | 1 |
| Galloway, MP | 1 |
| Borg, S | 1 |
| Kvande, H | 1 |
| Valverius, P | 1 |
| Kirch, DG | 1 |
| Jaskiw, G | 1 |
| Wyatt, RJ | 1 |
| Leckman, JF | 1 |
| Ort, S | 1 |
| Caruso, KA | 1 |
| Anderson, GM | 1 |
| Riddle, MA | 1 |
| Cohen, DJ | 1 |
| Pickar, D | 1 |
| Labarca, R | 1 |
| Doran, AR | 1 |
| Breier, A | 1 |
| Paul, SM | 1 |
| Papeschi, R | 1 |
| Theiss, P | 1 |
| Yamane, H | 1 |
| Kondo, H | 1 |
| Turnbull, MJ | 1 |
| Ballinger, BR | 1 |
1 review available for homovanillic acid and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
[Changes in metabolism of catecholamines and serotonin during alcohol withdrawal].
Topics: Antidepressive Agents, Second-Generation; Dopamine; Ethanol; Homovanillic Acid; Humans; Hydroxyindol | 1997 |
6 trials available for homovanillic acid and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
A phase 1 trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.
Topics: Administration, Cutaneous; Adult; Affect; Amphetamine; Amphetamines; Analysis of Variance; Cocaine; | 2009 |
Memory and plasma HVA changes in schizophrenia: are they episode markers?
Topics: Adult; Biomarkers; Cognition Disorders; Double-Blind Method; Haloperidol; Homovanillic Acid; Humans; | 1994 |
Plasma homovanillic acid and the dopamine transporter during cocaine withdrawal.
Topics: Adult; Carrier Proteins; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Gas Chromat | 1998 |
Clinical conditions and central dopamine metabolism in alcoholics during acute withdrawal under treatment with different pharmacological agents.
Topics: Adult; Aged; Amobarbital; Antipsychotic Agents; Butyrophenones; Double-Blind Method; Ethanol; Homova | 1986 |
Plasma amine metabolites before and after withdrawal from neuroleptic treatment in chronic schizophrenic inpatients.
Topics: Adolescent; Adult; Antipsychotic Agents; Brain; Catecholamines; Clinical Trials as Topic; Double-Bli | 1988 |
Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment.
Topics: Adult; Dopamine; Female; Fluphenazine; Homovanillic Acid; Humans; Male; Middle Aged; Psychiatric Sta | 1986 |
58 other studies available for homovanillic acid and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Alcohol Abstinence; Alcoholism; Animals; Benzazepines; | 2016 |
Reduction of group II metabotropic glutamate receptors during development of benzodiazepine dependence.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzodiazepines; Cerebral Cortex; Dopamine; Flumazenil; GAB | 2013 |
Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism].
Topics: Adult; Affect; Alcoholism; Carrier Proteins; Case-Control Studies; Corticotropin-Releasing Hormone; | 2002 |
Cerebrospinal fluid monoamine metabolites in cocaine patients: no relationship to cue-induced craving.
Topics: Adult; Cocaine; Cocaine-Related Disorders; Cues; Dopamine; Female; Homovanillic Acid; Humans; Hydrox | 2002 |
Baclofen reestablishes striatal and cortical dopamine concentrations during naloxone-precipitated withdrawal.
Topics: Animals; Baclofen; Cerebral Cortex; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry | 2003 |
Systemic morphine-induced release of serotonin in the rostroventral medulla is not mimicked by morphine microinjection into the periaqueductal gray.
Topics: Analgesics, Opioid; Animals; Drug Administration Routes; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Fentan | 2003 |
Individual differences in ethanol self-administration following withdrawal are associated with asymmetric changes in dopamine and serotonin in the medial prefrontal cortex and amygdala.
Topics: 3,4-Dihydroxyphenylacetic Acid; Alcohol Drinking; Amygdala; Animals; Behavior, Animal; Central Nervo | 2006 |
Allele distribution of a monoamine oxidase A gene promoter polymorphism in German alcoholics and in subgroups with severe forms of alcohol withdrawal and its influence on plasma homovanillic acid.
Topics: Alcoholism; Alleles; Germany; Homovanillic Acid; Humans; Monoamine Oxidase; Promoter Regions, Geneti | 2006 |
Dopamine and serotonin metabolites in rat cerebroventricular fluid following withdrawal of haloperidol or electroshock treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Electroshock; Haloperidol; Homovanillic Acid; Hum | 1984 |
Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Antipsychotic Agents; Apomorphine; Bindi | 1980 |
Comparison of the changes in central catecholamine systems following short- and long-term lithium treatment and the consequences of lithium withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catecholamines; Dopamine; Homovanillic Aci | 1984 |
[Cerebrospinal fluid monamine metabolites and cyclic nucleotides during alcoholic withdrawal syndrome].
Topics: Adult; Alcoholism; Brain; Cyclic AMP; Cyclic GMP; Female; Homovanillic Acid; Humans; Hydroxyindoleac | 1980 |
Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence.
Topics: Alcoholism; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kinetics; Phenylacetates; R | 1981 |
Monoamine metabolism during chronic benzodiazepine treatment and withdrawal.
Topics: Adult; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Female; Glycols; Homovanillic Acid | 1983 |
[Effect of chronic administration of lithium chloride on the development of dopamine receptor sensitivity during morphine withdrawal in rats].
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Chlorides; Corpus Striatum; Dopamine; Homovanillic Acid; Hu | 1981 |
Brain catecholamine metabolites and behavior in morphine withdrawal.
Topics: Animals; Behavior, Animal; Brain Chemistry; Catecholamines; Debrisoquin; Homovanillic Acid; Humans; | 1982 |
BehavioraL and biochemical changes caused by muscimol in mice withdrawN from haloperidol administration.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Humans; Male; | 1982 |
Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Brain; Brain Chemistry; Cerebral Cortex; Corpu | 1980 |
Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia.
Topics: Adult; Chromogranin A; Chromogranins; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Ac | 1994 |
Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia.
Topics: Adult; Age of Onset; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Logistic Mode | 1995 |
Morphine-stimulated metabolism of striatal and limbic dopamine is dissimilarly sensitized in rats upon withdrawal from chronic morphine treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Limbic System | 1994 |
Peripheral benzodiazepine receptors are decreased during cocaine withdrawal in humans.
Topics: Adult; Cocaine; Homovanillic Acid; Humans; Kinetics; Male; Middle Aged; Neutrophils; Radioligand Ass | 1994 |
Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. Analysis of circadian patterns using automated on-line microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Caudate Nucleus; Circadian Rhythm; Dopamine; F | 1996 |
Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Behavior, Animal; Dopamine; Homovanil | 1998 |
Nicotine withdrawal in the rat: role of alpha7 nicotinic receptors in the ventral tegmental area.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha7 Nicotinic Acetylcholine Receptor; Animals; Dopamine; Homovani | 1999 |
CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
Topics: Adult; Alcoholism; Behavior, Addictive; Biogenic Monoamines; Biomarkers; Case-Control Studies; Ethan | 1999 |
The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Caudate Nucleus; Corpus Striatum; Cotinine; Dopam | 1999 |
Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations.
Topics: Adult; Case-Control Studies; Dehydroepiandrosterone; Depression; Ethanol; Female; Homovanillic Acid; | 1999 |
Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Chronic Disease; Dopamine; Extracellular | 2000 |
Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome.
Topics: Aged; Analysis of Variance; Female; Homovanillic Acid; Humans; Male; Neuroleptic Malignant Syndrome; | 2001 |
Evidence for the role of brain norepinephrine and dopamine in "rebound" phenomenon seen during withdrawal after repeated exposure to benzodiazepines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Body Weight; Brain; Brain Chemistry; B | 1977 |
Neurochemistry of withdrawal emergent symptoms in children.
Topics: Antipsychotic Agents; Child; Cyclic AMP; Dyskinesia, Drug-Induced; Homovanillic Acid; Humans; Hydrox | 1977 |
Some neurochemical correlates of "rebound" phenomenon observed during withdrawal after long-term exposure to 1, 4-benzodiazepines.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Anti-Anxiety Agents; Brain; Brain Chemistry; Bromazepam; Di | 1978 |
Changes in the metabolism of biogenic amines in alcoholism--especially regarding CSF monoamine metabolites and serum DBH activity.
Topics: Adult; Aged; Alcoholism; Biogenic Amines; Dopamine beta-Hydroxylase; Female; Homovanillic Acid; Huma | 1979 |
Changes in striatal dopamine metabolism during precipitated morphine withdrawal.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzomorphans; Catechol O-Methyltransferase; Corpus Striatu | 1977 |
Gradients of biogenic amine metabolites in cerebrospinal fluid.
Topics: Alzheimer Disease; Amphetamine; Brain Diseases; Brain Neoplasms; Depression; Homovanillic Acid; Huma | 1975 |
Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
Topics: Animals; Apomorphine; Chlorpromazine; Clozapine; Corpus Striatum; Dibenzazepines; Dibenzoxazepines; | 1975 |
Does chronic morphine treatment induce a supersensitivity of dopamine receptors in rat brain?
Topics: Animals; Apomorphine; Benserazide; Brain; Corpus Striatum; Dopamine; Homovanillic Acid; Humans; Levo | 1975 |
Effect of ethanol dependence and withdrawal on the catecholamines in rat brain and heart.
Topics: Animals; Brain; Catecholamines; Depression, Chemical; Dopamine; Ethanol; Homovanillic Acid; Humans; | 1975 |
Dopaminergic responsivity during cocaine abstinence: a pilot study.
Topics: Adult; Carbidopa; Cocaine; Dopamine Agents; Drug Combinations; Growth Hormone; Homovanillic Acid; Hu | 1992 |
Effects of chronic treatment with ethanol and withdrawal of ethanol on levels of dopamine, 3,4-dihydroxyphenylacetic acid and homovanillic acid in the striatum of the rat. Influence of benzodiazepines, barbiturate and somatostatin.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Barbiturates; Benzodiazepines; Chromatography, High Pressur | 1992 |
Increased CSF HVA with craving in long-term abstinent cocaine abusers.
Topics: Adult; Arousal; Cocaine; Follow-Up Studies; Homovanillic Acid; Humans; Male; Motivation; Substance W | 1992 |
Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Homovanillic Acid; Humans; Psychiatric Statu | 1991 |
Chronic L-dopa treatment in the unilateral 6-OHDA rat: evidence for behavioral sensitization and biochemical tolerance.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Apomorphine; Carbidopa; Corpus Striatum; Denervation; Drug | 1991 |
Clinical phenomenology and neurobiology of cocaine abstinence: a prospective inpatient study.
Topics: Adult; Cocaine; Dopamine; Female; Growth Hormone; Homovanillic Acid; Hospitalization; Humans; Male; | 1991 |
Apparent synaptic dopamine deficiency induced by withdrawal from chronic cocaine treatment.
Topics: Animals; Brain Chemistry; Cocaine; Dialysis; Dopamine; Homovanillic Acid; Male; Motor Activity; Nucl | 1991 |
Dopaminergic sensitivity and cocaine abuse: response to apomorphine.
Topics: Adult; Anxiety; Apomorphine; Attention; Brain; Cocaine; Dopamine; Homovanillic Acid; Humans; Male; P | 1990 |
Urinary amine metabolite excretion in a patient with adrenergic hyperactivity state: reaction to phenelzine withdrawal and combined treatment.
Topics: Bipolar Disorder; Delirium; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Meta | 1986 |
The fall of homovanillic acid and 5-hydroxyindoleacetic acid concentrations in brains of mice withdrawn from repeated morphine treatment and their restoration by acute morphine administration.
Topics: Animals; Body Weight; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Morphine; M | 1987 |
CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
Topics: Adult; Chromatography, High Pressure Liquid; Chronic Disease; Haloperidol; Homovanillic Acid; Humans | 1989 |
The effect of neuroleptic discontinuation on psychopathology, involuntary movements, and biochemical measures in patients with persistent tardive dyskinesia.
Topics: Antipsychotic Agents; Brain; Dopamine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; F | 1989 |
Decrease in dopamine, its metabolites and noradrenaline in cerebrospinal fluid of schizophrenic patients after withdrawal of long-term neuroleptic treatment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Antipsychotic Agents; Chronic Disease; Dopamine; Female; Halo | 1985 |
Clinical ratings and plasma HVA during cocaine abstinence.
Topics: Adult; Cocaine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Substance | 1989 |
Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment.
Topics: Adult; Antipsychotic Agents; Dopamine beta-Hydroxylase; Dyskinesia, Drug-Induced; Female; Homovanill | 1985 |
Rebound phenomena in Tourette's syndrome after abrupt withdrawal of clonidine. Behavioral, cardiovascular, and neurochemical effects.
Topics: Adolescent; Blood Pressure; Child; Clonidine; Epinephrine; Homovanillic Acid; Humans; Male; Methoxyh | 1986 |
Serotonin and dopamine turnover after acute and chronic morphine administration.
Topics: Animals; Brain; Brain Chemistry; Dopamine; Drug Tolerance; Homovanillic Acid; Humans; Hydroxyindolea | 1974 |
CSF monoamine metabolites in alcoholism: a comparative study with depression.
Topics: Adult; Aged; Alcoholism; Depression; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Ma | 1974 |
Urinary excretion of monoamines and metabolites in patients dependent on and withdrawn from barbiturates.
Topics: Barbiturates; Catecholamines; Dopamine; Epinephrine; Female; Homovanillic Acid; Humans; Hydroxyindol | 1973 |